Aurinia Pharmaceuticals, Inc. (AUPH)
15.85
-0.03
(-0.19%)
USD |
NASDAQ |
Dec 12, 16:00
15.86
+0.02
(+0.09%)
After-Hours: 20:00
Aurinia Pharmaceuticals Gross Profit (Quarterly): 65.29M for Sept. 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0675M |
| Edesa Biotech, Inc. | -0.0258M |
| Lexaria Bioscience Corp. | 0.1526M |
| Xenon Pharmaceuticals, Inc. | -0.641M |
| ProMIS Neurosciences, Inc. | 0.00 |